Understanding Platelet Concentration and Gel Separation in PRP Preparation

The Science Behind Effective PRP: Concentration and Separation

Two variables sit at the heart of every PRP preparation: platelet concentration and separation quality. Together, they determine whether your PRP product contains a therapeutically meaningful dose of growth factors — or a diluted, contaminated preparation that underdelivers clinically.

This article is designed for practitioners who want to move beyond the basics and understand the biophysics of PRP preparation, so they can optimise their protocols and evaluate tube systems with scientific rigour.

What Is Platelet Concentration — and Why Does It Matter?

Whole blood contains approximately 150,000–400,000 platelets per microlitre (μL). PRP is defined as plasma with a platelet concentration above baseline — typically 2–8x the patient’s own baseline count.

The therapeutic rationale is straightforward: platelets are the primary delivery vehicle for growth factors (PDGF, TGF-β, VEGF, EGF, IGF-1). Higher platelet concentration = higher growth factor payload at the treatment site.

Concentration Thresholds in Clinical Research:

• 1–2x baseline: Subtherapeutic — unlikely to produce meaningful clinical effect
• 2–4x baseline: Minimum therapeutic range for most applications
• 4–6x baseline: Optimal range for orthopedic and hair restoration applications
• >6x baseline: Achievable with double-spin protocols; may be beneficial for wound healing

A 2014 systematic review in the American Journal of Sports Medicine found that PRP preparations with platelet concentrations below 1 million/μL (approximately 2.5x average baseline) showed inconsistent clinical outcomes, highlighting the importance of achieving adequate concentration.

Factors That Determine Platelet Concentration

1. Centrifugation Speed and Time

Centrifugation separates blood components by density using relative centrifugal force (RCF), measured in ×g. The relationship between speed, time, and platelet yield is nuanced:

• Too slow / too short: Incomplete separation; platelets remain distributed throughout the plasma, reducing concentration
• Too fast / too long: Platelet activation and aggregation during centrifugation; reduced viable platelet count in the final product
• Optimal range: 1,500–2,000 RPM (approximately 200–400 ×g) for 8–10 minutes for the first spin

2. Blood Draw Volume

Larger draw volumes yield more PRP. A 15 mL draw typically produces 3–5 mL of PRP; a 10 mL draw yields 2–3 mL. For applications requiring higher volumes (bilateral joints, large wound beds), multiple tubes should be processed simultaneously.

3. Anticoagulant Selection

ACD anticoagulant preserves platelet viability during centrifugation by preventing premature activation. Tubes using EDTA or heparin can cause platelet activation or inhibition, respectively, reducing the functional platelet count in the final product.

4. Patient Baseline Platelet Count

PRP concentration is relative to the patient’s own baseline. A patient with thrombocytopenia (low baseline platelets) will produce a lower-concentration PRP even with an optimal protocol. Pre-treatment CBC is advisable for patients with suspected haematological conditions.

Gel Separation: The Mechanics and the Clinical Significance

How Separator Gel Works

Thixotropic polyester gel is a viscoelastic material with a specific gravity (approximately 1.060–1.080 g/mL) that sits between the densities of plasma/platelets (1.025–1.035 g/mL) and red blood cells (1.080–1.110 g/mL). During centrifugation, the gel migrates upward through the denser RBC layer and settles at the interface, forming a stable physical barrier.

This barrier serves two critical functions:

1. Physical separation: Prevents RBCs from re-mixing with the PRP layer during and after centrifugation
2. Aspiration guide: Allows the practitioner to aspirate the entire plasma layer above the gel without risk of RBC contamination

Why RBC Contamination Matters

Red blood cells in PRP are not inert. They:

• Release haemoglobin, which is cytotoxic to fibroblasts and chondrocytes at high concentrations
• Increase the inflammatory burden of the injection, potentially causing post-injection flares
• Reduce the relative platelet concentration by diluting the PRP product
• Can cause discolouration and patient discomfort at the injection site

Studies comparing PRP preparations with and without gel separation consistently show lower RBC contamination and more consistent platelet recovery in gel-containing systems.

Gel Quality Variables

Not all separator gels perform equally. Key quality parameters include:

• Specific gravity consistency: Must be precisely calibrated to migrate correctly at standard centrifugation speeds
• Thermal stability: Gel must maintain its barrier function at room temperature and body temperature
• Biocompatibility: Must not leach compounds that affect platelet function (ISO 10993 testing)
• Barrier integrity: Must remain stable during aspiration and not fragment into the PRP layer

Single-Spin vs. Double-Spin: Concentration Trade-offs

Evaluating Your PRP System: Key Quality Metrics

When assessing a PRP tube system, request the following data from your supplier:

• Platelet Recovery Rate: Percentage of baseline platelets recovered in the final PRP product (target: ≥70%)
• Platelet Concentration Factor: Average fold-increase over baseline at standard centrifugation parameters
• RBC Contamination Data: Haematocrit of the final PRP product (target: <1%)
• Gel Migration Performance: Documented across a range of centrifugation speeds
• Batch-to-Batch Consistency: Coefficient of variation for platelet recovery across production batches

BIO PRIME provides full technical documentation including platelet recovery data, gel performance validation, and batch certificates of analysis. Our tubes are CE-marked and manufactured under ISO 13485-certified quality systems.

Practical Takeaways for Protocol Optimisation

• Always verify your centrifuge’s actual RCF output — RPM alone is insufficient without knowing rotor radius
• Use ACD anticoagulant to maximise platelet viability and growth factor release potential
• Choose gel-containing tubes when consistency and RBC-free product are priorities
• Document your protocol parameters (speed, time, draw volume) and track outcomes to build your own evidence base
• Request quality documentation from your tube supplier — platelet recovery data should be available for every batch

Contact BIO PRIME for technical documentation, protocol consultation, or to request a sample evaluation kit for your practice.